To ensure your progress is on track, youll meet with our medical provider monthly
The platform estimates one to two new GLP-1 drug launches per year beginning in 2026, with 39 GLP-1 medications currently in development
The SeekPeptides peptide calculator provides weight-based reference ranges for various peptides, though for retatrutide specifically, the clinical protocol doses (2mg, 4mg, 8mg, 12mg) remain the standard reference points
In early trials, some people have experienced: Diarrhoea Constipation Nausea Vomiting These are similar to those seen with other weight loss injections , and for many people, they tend to settle as the body adjusts
Transdermal delivery reliably works for small, fat soluble compounds, which is why a nicotine patch can succeed
3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects